Regenerative medicine product Stemchymal, an allogeneic adipose-derived mesenchymal stem cell treatment, missed the primary efficacy endpoints in two phase II spinocerebellar ataxia trials conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback